
    
      PROTOCOL OUTLINE: This is a randomized, double blind study. Patients are randomized to
      receive either albendazole and dexamethasone or placebo.

      Patients receive phenytoin daily starting on day 1 and continuing until seizure free for 1
      year. Albendazole and dexamethasone or placebo only is administered orally once daily on days
      5-15.

      Patients are asked to maintain a diary. Patients are followed on day 15 and 30, then every 3
      months for 3 years.

      Completion date provided represents the completion date of the grant per OOPD records
    
  